{"pmid":32234465,"title":"Recent Progress in understanding 2019 Novel Coronavirus associated with Human Respiratory Disease: Detection, Mechanism and Treatment.","text":["Recent Progress in understanding 2019 Novel Coronavirus associated with Human Respiratory Disease: Detection, Mechanism and Treatment.","Viral respiratory diseases such as the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), always pose severe threat to people. First identified in the late December 2019, in Wuhan, China, a novel coronavirus (2019-nCoV) has rampantly spread to lots of provinces in China, and multiple countries are affected. The viral outbreaks have stirred panic and emergency on public health around the world and the number of infections continues to rise. But the cause and consequence of the pneumonia still remain unknown. In order to effectively implement the epidemic prevention, early identification and diagnosis is critical to disease control. Herein we scrutinize a series of available studies by global scientists on the clinical manifestations, detection methods and treatment options of 2019 novel coronavirus pneumonia, also propose potential strategies for preventing the infection.","Int J Antimicrob Agents","Kang, Shuntong","Peng, Wenyao","Zhu, Yuhao","Lu, Shiyao","Zhou, Min","Lin, Wei","Wu, Wenfang","Huang, Shu","Jiang, Liping","Luo, Xuan","Deng, Meichun","32234465"],"abstract":["Viral respiratory diseases such as the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), always pose severe threat to people. First identified in the late December 2019, in Wuhan, China, a novel coronavirus (2019-nCoV) has rampantly spread to lots of provinces in China, and multiple countries are affected. The viral outbreaks have stirred panic and emergency on public health around the world and the number of infections continues to rise. But the cause and consequence of the pneumonia still remain unknown. In order to effectively implement the epidemic prevention, early identification and diagnosis is critical to disease control. Herein we scrutinize a series of available studies by global scientists on the clinical manifestations, detection methods and treatment options of 2019 novel coronavirus pneumonia, also propose potential strategies for preventing the infection."],"journal":"Int J Antimicrob Agents","authors":["Kang, Shuntong","Peng, Wenyao","Zhu, Yuhao","Lu, Shiyao","Zhou, Min","Lin, Wei","Wu, Wenfang","Huang, Shu","Jiang, Liping","Luo, Xuan","Deng, Meichun"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234465","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijantimicag.2020.105950","keywords":["Detection","Mechanism","Novel coronavirus","Treatment"],"source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism","Treatment"],"weight":1,"_version_":1662996001673183232,"score":7.6048946,"similar":[{"pmid":32220177,"title":"[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].","text":["[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].","This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic.","Sichuan Da Xue Xue Bao Yi Xue Ban","Luan, Rong-Sheng","Wang, Xin","Sun, Xin","Chen, Xing-Shu","Zhou, Tao","Liu, Quan-Hui","Lu, Xin","Wu, Xian-Ping","Gu, Dong-Qing","Tang, Ming-Shuang","Cui, Hui-Jie","Shan, Xue-Feng","Ouyang, Jing","Zhang, Ben","Zhang, Wei","Sichuan University Covid-, Emergency Research Group","32220177"],"abstract":["This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic."],"journal":"Sichuan Da Xue Xue Bao Yi Xue Ban","authors":["Luan, Rong-Sheng","Wang, Xin","Sun, Xin","Chen, Xing-Shu","Zhou, Tao","Liu, Quan-Hui","Lu, Xin","Wu, Xian-Ping","Gu, Dong-Qing","Tang, Ming-Shuang","Cui, Hui-Jie","Shan, Xue-Feng","Ouyang, Jing","Zhang, Ben","Zhang, Wei","Sichuan University Covid-, Emergency Research Group"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32220177","week":"202013|Mar 23 - Mar 29","doi":"10.12182/20200360505","keywords":["Coronavirus disease 2019","Epidemic prevention and control","Epidemiology","Treatment"],"source":"PubMed","topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1663095625754869760,"score":174.5244},{"pmid":32143502,"title":"Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.","text":["Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.","Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the Middle East Respiratory Syndrome-CoV (MERS-CoV) outbreak in 2012. Currently, the world is concerned about the 2019 novel CoV (SARS-CoV-2) that was initially identified in the city of Wuhan, China in December 2019. Patients presented with severe viral pneumonia and respiratory illness. The number of cases has been mounting since then. As of late February 2020, tens of thousands of cases and several thousand deaths have been reported in China alone, in addition to thousands of cases in other countries. Although the fatality rate of SARS-CoV-2 is currently lower than SARS-CoV, the virus seems to be highly contagious based on the number of infected cases to date. In this review, we discuss structure, genome organization, entry of CoVs into target cells, and provide insights into past and present outbreaks. The future of human CoV outbreaks will not only depend on how the viruses will evolve, but will also depend on how we develop efficient prevention and treatment strategies to deal with this continuous threat.","Pathogens","Ashour, Hossam M","Elkhatib, Walid F","Rahman, Md Masudur","Elshabrawy, Hatem A","32143502"],"abstract":["Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the Middle East Respiratory Syndrome-CoV (MERS-CoV) outbreak in 2012. Currently, the world is concerned about the 2019 novel CoV (SARS-CoV-2) that was initially identified in the city of Wuhan, China in December 2019. Patients presented with severe viral pneumonia and respiratory illness. The number of cases has been mounting since then. As of late February 2020, tens of thousands of cases and several thousand deaths have been reported in China alone, in addition to thousands of cases in other countries. Although the fatality rate of SARS-CoV-2 is currently lower than SARS-CoV, the virus seems to be highly contagious based on the number of infected cases to date. In this review, we discuss structure, genome organization, entry of CoVs into target cells, and provide insights into past and present outbreaks. The future of human CoV outbreaks will not only depend on how the viruses will evolve, but will also depend on how we develop efficient prevention and treatment strategies to deal with this continuous threat."],"journal":"Pathogens","authors":["Ashour, Hossam M","Elkhatib, Walid F","Rahman, Md Masudur","Elshabrawy, Hatem A"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32143502","week":"202010|Mar 02 - Mar 08","doi":"10.3390/pathogens9030186","keywords":["2019-nCoV","COVID-19","MERS","SARS","SARS-CoV-2"],"source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Treatment","Mechanism"],"weight":1,"_version_":1663095626039033856,"score":172.10393},{"pmid":32112977,"pmcid":"PMC7105032","title":"World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).","text":["World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).","An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.","Int J Surg","Sohrabi, Catrin","Alsafi, Zaid","O'Neill, Niamh","Khan, Mehdi","Kerwan, Ahmed","Al-Jabir, Ahmed","Iosifidis, Christos","Agha, Riaz","32112977"],"abstract":["An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19."],"journal":"Int J Surg","authors":["Sohrabi, Catrin","Alsafi, Zaid","O'Neill, Niamh","Khan, Mehdi","Kerwan, Ahmed","Al-Jabir, Ahmed","Iosifidis, Christos","Agha, Riaz"],"date":"2020-03-01T11:00:00Z","year":2020,"_id":"32112977","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.ijsu.2020.02.034","keywords":["COVID-19","Global health emergency","Novel coronavirus","Viral transmission","Wuhan"],"source":"PubMed","locations":["China","Hubei","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Mechanism","Diagnosis","Prevention"],"weight":1,"_version_":1663095626114531328,"score":170.8287},{"pmid":31944312,"title":"Recent advances in the detection of respiratory virus infection in humans.","text":["Recent advances in the detection of respiratory virus infection in humans.","Respiratory tract viral infection caused by viruses or bacteria is one of the most common diseases in human worldwide, while those caused by emerging viruses, such as the novel coronavirus, 2019-nCoV that caused the pneumonia outbreak in Wuhan, China most recently, have posed great threats to global public health. Identification of the causative viral pathogens of respiratory tract viral infections is important to select an appropriate treatment, save people's lives, stop the epidemics, and avoid unnecessary use of antibiotics. Conventional diagnostic tests, such as the assays for rapid detection of antiviral antibodies or viral antigens, are widely used in many clinical laboratories. With the development of modern technologies, new diagnostic strategies, including multiplex nucleic acid amplification and microarray-based assays, are emerging. This review summarizes currently available and novel emerging diagnostic methods for the detection of common respiratory viruses, such as influenza virus, human respiratory syncytial virus, coronavirus, human adenovirus, and human rhinovirus. Multiplex assays for simultaneous detection of multiple respiratory viruses are also described. It is anticipated that such data will assist researchers and clinicians to develop appropriate diagnostic strategies for timely and effective detection of respiratory virus infections.","J Med Virol","Zhang, Naru","Wang, Lili","Deng, Xiaoqian","Liang, Ruiying","Su, Meng","He, Chen","Hu, Lanfang","Su, Yudan","Ren, Jing","Yu, Fei","Du, Lanying","Jiang, Shibo","31944312"],"abstract":["Respiratory tract viral infection caused by viruses or bacteria is one of the most common diseases in human worldwide, while those caused by emerging viruses, such as the novel coronavirus, 2019-nCoV that caused the pneumonia outbreak in Wuhan, China most recently, have posed great threats to global public health. Identification of the causative viral pathogens of respiratory tract viral infections is important to select an appropriate treatment, save people's lives, stop the epidemics, and avoid unnecessary use of antibiotics. Conventional diagnostic tests, such as the assays for rapid detection of antiviral antibodies or viral antigens, are widely used in many clinical laboratories. With the development of modern technologies, new diagnostic strategies, including multiplex nucleic acid amplification and microarray-based assays, are emerging. This review summarizes currently available and novel emerging diagnostic methods for the detection of common respiratory viruses, such as influenza virus, human respiratory syncytial virus, coronavirus, human adenovirus, and human rhinovirus. Multiplex assays for simultaneous detection of multiple respiratory viruses are also described. It is anticipated that such data will assist researchers and clinicians to develop appropriate diagnostic strategies for timely and effective detection of respiratory virus infections."],"journal":"J Med Virol","authors":["Zhang, Naru","Wang, Lili","Deng, Xiaoqian","Liang, Ruiying","Su, Meng","He, Chen","Hu, Lanfang","Su, Yudan","Ren, Jing","Yu, Fei","Du, Lanying","Jiang, Shibo"],"date":"2020-01-17T11:00:00Z","year":2020,"_id":"31944312","week":"20203|Jan 13 - Jan 19","doi":"10.1002/jmv.25674","keywords":["*adenovirus","*coronavirus","*diagnostic methods","*influenza virus","*respiratory syncytial virus","*respiratory viral infection","*rhinovirus"],"source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1662334544709156864,"score":169.59325},{"pmid":32245083,"title":"SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","text":["SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.","Pathogens","Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D","32245083"],"abstract":["In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes."],"journal":"Pathogens","authors":["Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245083","week":"202014|Mar 30 - Apr 05","doi":"10.3390/pathogens9030231","keywords":["COVID-19","Coronavirus","SARS","SARS-CoV-2","Wuhan","pandemic"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment","Diagnosis"],"weight":1,"_version_":1663169699597254656,"score":154.0385}]}